sb 203580 has been researched along with 8-chloro-cyclic adenosine monophosphate in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (8-chloro-cyclic adenosine monophosphate) | Trials (8-chloro-cyclic adenosine monophosphate) | Recent Studies (post-2010) (8-chloro-cyclic adenosine monophosphate) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 269 | 3 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, YH; Choi, KY; Han, JH; Hong, SH | 1 |
1 other study(ies) available for sb 203580 and 8-chloro-cyclic adenosine monophosphate
Article | Year |
---|---|
Involvement of AMP-activated protein kinase and p38 mitogen-activated protein kinase in 8-Cl-cAMP-induced growth inhibition.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; HeLa Cells; HL-60 Cells; Humans; Imidazoles; K562 Cells; Mutation; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Ribonucleotides; Signal Transduction | 2009 |